Ipsilateral Renal Cell Carcinoma and Transitional Cell Carcinoma: Synchronous Dual Primary Malignancies of Kidney

Md Ali Osama; Arupparna Sen Gupta; Seema Rao

doi:10.21276/apalm.3124

Ipsilateral Renal Cell Carcinoma and Transitional Cell Carcinoma: Synchronous Dual Primary Malignancies of Kidney

Authors

Md Ali Osama Department of Pathology, Lady Hardinge Medical College
Arupparna Sen Gupta Department of Histopathology, Sir Gangaram Hospital
Seema Rao Department of Histopathology, Sir Gangaram Hospital https://orcid.org/0000-0001-6525-2557

DOI:

https://doi.org/10.21276/apalm.3124

Keywords:

Renal Cell Carcinoma, Synchronous, Transitional Cell Carcinoma, Ipsilateral, kidney

References

Wong MCS, Goggins WB, Yip BHK, et al. Incidence and mortality of kidney cancer: temporal patterns and global trends in 39 countries. Sci Rep 2017; 7: 15698.

Kirkali Z, Tuzel E. Transitional cell carcinoma of the ureter and renal pelvis. Crit Rev Oncol Hematol 2003; 47: 155-69.

Qi N, Chen Y, Gong K, Li H. Concurrent renal cell carcinoma and urothelial carcinoma: long-term follow-up study of 27 cases. World J Surg Oncol 2018; 16: 16.

Michel K, Belldegrun A. Synchronous RCC and TCC of the kidney in a patient with multiple recurrent bladder tumors. Rev Urol 1999; 1: 99-103.

Leelamma JP, Pothen L, Ramachandran NP. Synchronous urothelial carcinoma of renal pelvis and ipsilateral renal cell carcinoma. Saudi J Health Sci 2017; 6: 110-2

Park S, Hong B, Kim CS, Ahn H. The impact of tumor location on prognosis of transitional cell carcinoma of the upper urinary tract. J Urol 2004; 171(2 Pt 1): 621-5.

Downloads

Published

02-12-2021

How to Cite

Osama MA, Gupta AS, Rao S. Ipsilateral Renal Cell Carcinoma and Transitional Cell Carcinoma: Synchronous Dual Primary Malignancies of Kidney. Ann of Pathol and Lab Med [Internet]. 2021 Dec. 2 [cited 2024 Nov. 19];8(11):I4-6. Available from: https://pacificejournals.com/journal/index.php/apalm/article/view/3124

Vancouver

Download Citation

Issue

Vol. 8 No. 11 (2021)

Section

Image

License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access at http://opcit.eprints.org/oacitation-biblio.html).